Depakote (divalproex sodium) is a prescription medication that is used to treat seizures, epilepsy, migraine headaches, and bipolar disorders. It works by boosting gamma amminobutyric acid (GABA) productions in the brain.
Depakote was approved by the FDA in 1983 and approved for generic use in 2008. Depakote and its generics (divalproex sodium) are manufactured by Abbott Pharmaceuticals, Teva Pharmaceuticals, Lupin Pharmaceuticals, Sun Pharmaceuticals, Mylan, Dr. Reddy’s Laboratories and Sandoz.
The FDA has received reports of birth defects in pregnant women who took anti-seizure medication, Depakote. These reports resulted in an FDA mandated packaging change and a warning to patients: pregnant women, or those considering pregnancy, should consider another medication to treat their condition. A startling statistic was compiled, by the North American Antiepileptic Drug Pregnancy Registry, showing that the use of Depakote and its generics put infants born to these mothers at four times the risk of suffering a congenital malformation.
These are the possible birth defects associated with Depakote use according to the FDA, the AED Pregnancy Registry, and medical research findings:
Medical experts have warned about the dangers associated with Depakote for over a decade, yet the drug was still prescribed to thousands of patients. Now, the drug’s manufacturer, Abbott Pharmaceuticals, and manufacturers of the generics are facing lawsuits filed by families whose infants have suffered tragic, life-altering disabilities. If you or a loved one has experienced a side effect associated with Depakote use during pregnancy, you may be eligible for a cash award settlement.
We offer free, no obligation consultations via phone or the form on this website.